• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

3%苯酚水溶液内镜下硬化治疗后食管的形态学变化

Morphological changes in esophagus following endoscopic sclerotherapy with 3% aqueous phenol.

作者信息

Mathur S K, Vora I M, Supe A N, Plumber S T, Naik S R

机构信息

Department of Surgery, Seth G S Medical College, Parel, Bombay.

出版信息

Indian J Gastroenterol. 1990 Jul;9(3):213-5.

PMID:2373532
Abstract

Autopsy studies have shown that a majority of sclerosants presently used for endoscopic variceal sclerotherapy achieve their end result by a process of necrotizing inflammation of the esophageal wall followed by fibrosis and thrombosis, rather than bland thrombosis of varices. We have been using 3% phenol in water for variceal sclerotherapy and found it to be an effective sclerosant. To study the effect of this sclerosant on varices and the esophageal wall, autopsies were performed in 15 patients who died following sclerotherapy. Histopathological examination of sections from the esophagus showed (a) fresh thrombus in the varices immediately following injection, (b) intimal damage with medial sclerosis and superficial mucosal ulceration after one week, (c) organisation and recanalization with marked medial sclerosis at 3-4 weeks, and (d) complete obliteration of varices after 6-12 weeks. None of the patients was found to have esophageal necrosis, perforation or mediastinitis. Thus, 3% aqueous phenol appears to be an effective and safe sclerosant for variceal sclerotherapy.

摘要

尸检研究表明,目前用于内镜下静脉曲张硬化治疗的大多数硬化剂,其最终效果是通过食管壁坏死性炎症、随后纤维化和血栓形成的过程实现的,而不是单纯的静脉曲张血栓形成。我们一直在使用3%的水合苯酚进行静脉曲张硬化治疗,并发现它是一种有效的硬化剂。为了研究这种硬化剂对静脉曲张和食管壁的影响,对15例硬化治疗后死亡的患者进行了尸检。食管切片的组织病理学检查显示:(a)注射后立即在静脉曲张内出现新鲜血栓;(b)一周后内膜损伤伴中层硬化和浅表黏膜溃疡;(c) 3 - 4周时血栓机化再通,中层硬化明显;(d) 6 - 12周后静脉曲张完全闭塞。未发现患者有食管坏死、穿孔或纵隔炎。因此,3%水合苯酚似乎是一种用于静脉曲张硬化治疗的有效且安全的硬化剂。

相似文献

1
Morphological changes in esophagus following endoscopic sclerotherapy with 3% aqueous phenol.3%苯酚水溶液内镜下硬化治疗后食管的形态学变化
Indian J Gastroenterol. 1990 Jul;9(3):213-5.
2
Endoscopic esophageal variceal sclerotherapy using 3% aqueous phenol.使用3%苯酚水溶液的内镜下食管静脉曲张硬化疗法。
Gastrointest Endosc. 1992 Mar-Apr;38(2):152-7. doi: 10.1016/s0016-5107(92)70381-2.
3
Esophageal endoscopic sclerotherapy in children using 3% aqueous phenol.
Indian J Gastroenterol. 1994 Jan;13(1):1-4.
4
[Comparative histologic studies following esophageal varices sclerosing with different substances].[不同物质硬化治疗食管静脉曲张后的组织学对比研究]
Leber Magen Darm. 1983 Sep;13(5):215-22.
5
[Experiences with endoscopic sclerosing of esophageal varices].[食管静脉曲张内镜下硬化治疗的经验]
Dtsch Z Verdau Stoffwechselkr. 1984;44(5):209-18.
6
Pathological studies on esophageal varices treated with injection sclerotherapy.注射硬化疗法治疗食管静脉曲张的病理学研究
Jpn J Surg. 1985 Jan;15(1):30-5. doi: 10.1007/BF02469854.
7
Portal vein thrombosis complicating endoscopic variceal sclerotherapy. Convincing further evidence.门静脉血栓形成并发内镜下静脉曲张硬化治疗。进一步的确凿证据。
Dig Dis Sci. 1991 Aug;36(8):1164-7. doi: 10.1007/BF01297467.
8
Sclerosants for variceal sclerotherapy: a critical appraisal.
Am J Gastroenterol. 1990 Jun;85(6):641-9.
9
Effects of sodium tetradecyl sulfate endoscopic variceal sclerotherapy on the esophagus. A prospective clinical and histopathologic study.十四烷基硫酸钠内镜下静脉曲张硬化疗法对食管的影响。一项前瞻性临床和组织病理学研究。
J Clin Gastroenterol. 1987 Dec;9(6):635-43. doi: 10.1097/00004836-198712000-00006.
10
Clinical evaluation of combined endoscopic variceal ligation and sclerotherapy of gastric varices in liver cirrhosis.肝硬化患者胃静脉曲张内镜下套扎术联合硬化剂注射治疗的临床评估
Endoscopy. 2003 Nov;35(11):940-5. doi: 10.1055/s-2003-43475.

引用本文的文献

1
The three-dimensional structure of human β-endorphin amyloid fibrils.人β-内啡肽淀粉样纤维的三维结构。
Nat Struct Mol Biol. 2020 Dec;27(12):1178-1184. doi: 10.1038/s41594-020-00515-z. Epub 2020 Oct 12.